The New York-based healthcare investor beat its $1.75 billion goal for OrbiMed Royalty and Credit Opportunities Fund V. The fund, which closed on Friday, follows the $1.71 billion OrbiMed raised for ...

On August 6, 2025, the U.S. Securities and Exchange Commission (SEC) announced a settled enforcement action against MUFG Securities EMEA plc, a UK-based security-based swap dealer (SBSD) registered ...

The Palo Alto-based venture firm Frazier Life Sciences has closed a new venture capital fund for startup creation and investing in early-stage biotechnology companies, raising $1.3 billion.